HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of human cancer by modulation of chronic inflammatory processes.

Abstract
Chronic inflammation induced by biological, chemical and physical factors has been associated with increased risk of human cancer at various sites. Inflammation facilitates the initiation of normal cells and their growth and progression to malignancy through production of pro-inflammatory cytokines and diverse reactive oxygen and nitrogen species. These also activate signaling molecules involved in inflammation and carcinogenesis such as nuclear transcription factor (NF-kappaB), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Several chemopreventive agents act through inhibition of signaling pathways (e.g. NF-kappaB), inhibition of oxidant-generating enzymes (e.g. iNOS) and mediators of inflammation (e.g. COX-2), scavenging reactive oxygen and nitrogen species, and modulation of xenobiotic-metabolizing enzymes (especially phase II enzyme induction). Some anti-inflammatory drugs have been tested in clinical trials to prevent human cancer at several sites. Better understanding of the molecular mechanisms by which chronic inflammation increases cancer risk will lead to further development of new strategies for cancer prevention at many sites.
AuthorsHiroshi Ohshima, Hiroshi Tazawa, Bakary S Sylla, Tomohiro Sawa
JournalMutation research (Mutat Res) Vol. 591 Issue 1-2 Pg. 110-22 (Dec 11 2005) ISSN: 0027-5107 [Print] Netherlands
PMID16083916 (Publication Type: Journal Article, Review)
Chemical References
  • Anticarcinogenic Agents
  • Cytokines
  • NF-kappa B
  • Reactive Nitrogen Species
  • Reactive Oxygen Species
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
Topics
  • Animals
  • Anticarcinogenic Agents (metabolism, therapeutic use)
  • Cyclooxygenase 2 (metabolism)
  • Cytokines (immunology)
  • Humans
  • Inflammation (metabolism)
  • NF-kappa B (metabolism)
  • Neoplasms (immunology, prevention & control, therapy)
  • Nitric Oxide Synthase Type II (metabolism)
  • Reactive Nitrogen Species (immunology)
  • Reactive Oxygen Species (immunology)
  • Signal Transduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: